Impact of sequencing of androgen receptor-signaling inhibition and radiotherapy in prostate cancer: importance of homologous recombination disruption

被引：0
|
作者：
Steven G. Allen
Chao Zhang
Shawn Malone
Soumyajit Roy
Robert T. Dess
William C. Jackson
Rohit Mehra
Corey Speers
Arul M. Chinnaiyan
Yilun Sun
Daniel E. Spratt
机构：
[1] University of Michigan,Department of Radiation Oncology
[2] Ottawa Hospital Research Institute,Department of Radiation Oncology, The Ottawa Hospital Cancer Center
[3] University of Michigan,Department of Pathology
[4] Case Western Reserve University,Department of Radiation Oncology, UH Seidman Cancer Center
[5] University of Michigan,Rogel Cancer Center and Michigan Center for Translational Pathology
[6] Case Western Reserve University,Department of Population Quantitative Health Sciences
来源：
World Journal of Urology | 2023年 / 41卷
关键词：
Prostate cancer; Androgen receptor; Adjuvant hormone therapy; Radiotherapy; Homologous recombination;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3877 / 3887
页数：10
相关论文
共 50 条
  • [1] Impact of sequencing of androgen receptor-signaling inhibition and radiotherapy in prostate cancer: importance of homologous recombination disruption
    Allen, Steven G.
    Zhang, Chao
    Malone, Shawn
    Roy, Soumyajit
    Dess, Robert T.
    Jackson, William C.
    Mehra, Rohit
    Speers, Corey
    Chinnaiyan, Arul M.
    Sun, Yilun
    Spratt, Daniel E.
    WORLD JOURNAL OF UROLOGY, 2023, 41 (12) : 3877 - 3887
  • [2] Androgen receptor signaling and mutations in prostate cancer
    Koochekpour, Shahriar
    ASIAN JOURNAL OF ANDROLOGY, 2010, 12 (05) : 639 - 657
  • [3] Sequencing the transcriptional network of androgen receptor in prostate cancer
    Chng, Kern Rei
    Cheung, Edwin
    CANCER LETTERS, 2013, 340 (02) : 254 - 260
  • [4] Androgen receptor signaling in prostate cancer
    Culig, Zoran
    Santer, Frederic R.
    CANCER AND METASTASIS REVIEWS, 2014, 33 (2-3) : 413 - 427
  • [5] Androgen receptor signaling in prostate cancer
    Zoran Culig
    Frédéric R. Santer
    Cancer and Metastasis Reviews, 2014, 33 : 413 - 427
  • [6] Androgen Receptor Signaling in Prostate Cancer Genomic Subtypes
    Jillson, Lauren K.
    Yette, Gabriel A.
    Laajala, Teemu D.
    Tilley, Wayne D.
    Costello, James C.
    Cramer, Scott D.
    CANCERS, 2021, 13 (13)
  • [7] Androgen Receptor Signaling in Prostate Cancer and Therapeutic Strategies
    Jacob, Aasems
    Raj, Rishi
    Allison, Derek B.
    Myint, Zin W.
    CANCERS, 2021, 13 (21)
  • [8] Auranofin lethality to prostate cancer includes inhibition of proteasomal deubiquitinases and disrupted androgen receptor signaling
    Liu, Ningning
    Guo, Zhiqiang
    Xia, Xiaohong
    Liao, Yuning
    Zhang, Fangcheng
    Huang, Chuyi
    Liu, Yuan
    Deng, Xiumei
    Jiang, Lili
    Wang, Xuejun
    Liu, Jinbao
    Huang, Hongbiao
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2019, 846 : 1 - 11
  • [9] Regulation of androgen receptor signaling in prostate cancer
    Dehm, SM
    Tindall, DJ
    EXPERT REVIEW OF ANTICANCER THERAPY, 2005, 5 (01) : 63 - 74
  • [10] Thyroid and androgen receptor signaling are antagonized by μ-Crystallin in prostate cancer
    Aksoy, Osman
    Pencik, Jan
    Hartenbach, Markus
    Moazzami, Ali A.
    Schlederer, Michaela
    Balber, Theresa
    Varady, Adam
    Philippe, Cecile
    Baltzer, Pascal A.
    Mazumder, Bismoy
    Whitchurch, Jonathan B.
    Roberts, Christopher J.
    Haitel, Andrea
    Herac, Merima
    Susani, Martin
    Mitterhauser, Markus
    Marculescu, Rodrig
    Stangl-Kremser, Judith
    Hassler, Melanie R.
    Kramer, Gero
    Shariat, Shahrokh F.
    Turner, Suzanne D.
    Tichy, Boris
    Oppelt, Jan
    Pospisilova, Sarka
    Hartenbach, Sabrina
    Tangermann, Simone
    Egger, Gerda
    Neubauer, Heidi A.
    Moriggl, Richard
    Culig, Zoran
    Greiner, Georg
    Hoermann, Gregor
    Hacker, Marcus
    Heery, David M.
    Merkel, Olaf
    Kenner, Lukas
    INTERNATIONAL JOURNAL OF CANCER, 2021, 148 (03) : 731 - 747
12345